tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IT:REC Stock Latest News

Recordati Updates on Share Buyback Program Execution
Company AnnouncementsRecordati Updates on Share Buyback Program Execution
4d ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany Announcements
Recordati Updates on Share Buyback Program Execution
11d ago
Recordati Engages in Strategic Share Transactions
PremiumCompany Announcements
Recordati Engages in Strategic Share Transactions
12d ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany Announcements
Recordati Updates on Share Buyback Program Execution
18d ago
Recordati price target raised to EUR 56 from EUR 55.50 at RBC Capital
PremiumThe Fly
Recordati price target raised to EUR 56 from EUR 55.50 at RBC Capital
25d ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany AnnouncementsRecordati Updates on Share Buyback Program Execution
26d ago
Amarin announces exclusive license, supply agreement with Recordati
Premium
The Fly
Amarin announces exclusive license, supply agreement with Recordati
26d ago
AMRN
Recordati Updates on Share Buyback Program Execution
Premium
Company Announcements
Recordati Updates on Share Buyback Program Execution
1M ago
Recordati Updates on Share Buyback Program
PremiumCompany Announcements
Recordati Updates on Share Buyback Program
1M ago
Recordati price target raised to EUR 67 from EUR 65 at JPMorgan
PremiumThe Fly
Recordati price target raised to EUR 67 from EUR 65 at JPMorgan
1M ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany Announcements
Recordati Updates on Share Buyback Program Execution
1M ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany Announcements
Recordati Updates on Share Buyback Program Execution
2M ago
Recordati price target raised to EUR 55.50 from EUR 55 at RBC Capital
PremiumThe FlyRecordati price target raised to EUR 55.50 from EUR 55 at RBC Capital
2M ago
Recordati Updates on Share Buyback Program Execution
Premium
Company Announcements
Recordati Updates on Share Buyback Program Execution
2M ago
Recordati Updates on Share Buyback Program Execution
Premium
Company Announcements
Recordati Updates on Share Buyback Program Execution
2M ago
Recordati Reports Strong Q1 2025 Results with Double-Digit Revenue Growth
PremiumCompany Announcements
Recordati Reports Strong Q1 2025 Results with Double-Digit Revenue Growth
2M ago
Recordati Updates on Share Buyback Program Execution
PremiumCompany Announcements
Recordati Updates on Share Buyback Program Execution
2M ago
Recordati Releases Shareholders’ Meeting Voting Summary
PremiumCompany Announcements
Recordati Releases Shareholders’ Meeting Voting Summary
3M ago
Recordati Launches Share Buyback Program to Support Management Incentives
PremiumCompany Announcements
Recordati Launches Share Buyback Program to Support Management Incentives
3M ago
Recordati Approves 2024 Financials and Appoints New Board
PremiumCompany AnnouncementsRecordati Approves 2024 Financials and Appoints New Board
3M ago
FDA Approves Expanded Use of Recordati’s ISTURISA® for Cushing’s Syndrome
Premium
Company Announcements
FDA Approves Expanded Use of Recordati’s ISTURISA® for Cushing’s Syndrome
3M ago
Recordati Discloses Treasury Share Transactions and Buy-Back Program
Premium
Company Announcements
Recordati Discloses Treasury Share Transactions and Buy-Back Program
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >